SKI Market

A+| A| A-|

Indian Indices

Sensex

74,243.34 -116.67
( -0.16%)

Global Indices

Nasdaq

51,596.42 888.35
(1.75%)

Dow Jones

7,607.58 32.90
(0.43%)

Hang Seng

66,711.59 -759.10
(-1.13%)

Nikkei 225

10,374.30 13.98
(0.13%)

Forex

USD-INR

95.72 0.48
(0.51%)

EUR-INR

111.14 0.31
(0.28%)

GBP-INR

128.64 0.40
(0.31%)

JPY-INR

0.60 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kimia Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530313

INE285U01025

3.7455607

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

21.09

156.65

EPS(TTM)

Face Value()

Div & Yield %

1.57

Back

Board of Dilip Buildcon recommends final dividend

May 14,2026

Dilip Buildcon announced that the Board of Directors of the Company at its meeting held on 14 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

74,243.34 -116.67 ( -0.16%)

51,596.42 888.35 (1.75%)

7,607.58 32.90 (0.43%)

66,711.59 -759.10 (-1.13%)

10,374.30 13.98 (0.13%)

95.72 0.48 (0.51%)

111.14 0.31 (0.28%)

128.64 0.40 (0.31%)

0.60 0.00 (0.43%)